Safe Administration of Multiple Doses from a Single Vial of Intravitreal Anti-VEGF Lucentis
Background: Anti-VEGF, Intravitreal ranibizumab (Lucentis) has revolutionised the treatment of retinal vascular diseases. However, the high cost remains a significant barrier in resource-limited settings. This study evaluates the safety of administering three intravitreal injections from a single...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Liaquat National Hospital and Medical College
2025-12-01
|
| Ráidu: | Journal of Liaquat National Hospital |
| Fáttát: | |
| Liŋkkat: | https://journals.lnh.edu.pk/jlnh/pdf/093b1b55-0262-42e6-ae4d-8274149d7023.pdf |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|